VitaSpring Biomedical Co. Ltd. (VSBC)
OTCMKTS · Delayed Price · Currency is USD
0.0318
0.00 (0.00%)
At close: Oct 8, 2026
VitaSpring Biomedical Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.58M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2026 | - | - | - |
| Jan 31, 2025 | - | - | - |
| Jan 31, 2024 | - | - | - |
| Jan 31, 2023 | - | - | - |
| Jan 31, 2022 | 5.61M | 5.37M | 2,161.56% |
| Jan 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CASI Pharmaceuticals | 20.11M |
| International Stem Cell | 9.51M |
| BioAtla | 8.50M |
| Pacific Software | 2.40M |
| Vaccinex | 601.00K |
| GPL Holdings | 376.54K |
| Enzolytics | 46.59K |
| Aditxt | 14.34K |